02Apr/14

Researchers warn heart failure care in the UK is 'inadequate' – Yorkshire Post

Organ Failure

Yorkshire Post

Researchers warn heart failure care in the UK is ‘inadequate’
Yorkshire Post
The findings by a team at Durham University and Darlington Memorial Hospital, funded by the charity Heart Research UK in Leeds, detail inadequacies in heart failure care, as well as an uncoordinated approach to diagnosis and management of the condition …
CARE of heart failure patients in the UK is inadequate and has not changed in …The Northern Echo
Heart failure failures pinpointed in reportITV News

all 14 news articles »
01Apr/14

It's Time to Address the Public Health Threat of Chronic Kidney Disease … – Roll Call

Organ Failure

It’s Time to Address the Public Health Threat of Chronic Kidney Disease …
Roll Call
Chronic kidney disease came as a surprise to Nancy Vice of Warminster, Pa. Severe, unexplained back pain at age 27 sent her to the hospital, where she received her diagnosis and learned she would immediately have to begin dialysis or receive a kidney …
Trillium clinic assists those with kidney diseaseMississauga

all 3 news articles »
01Apr/14

MADIT-CRT: Resynchronization Ups Survival in Patients with Mild Heart Failure … – TCTMD

Organ Failure

MADIT-CRT: Resynchronization Ups Survival in Patients with Mild Heart Failure …
TCTMD
Among patients with mild heart failure, only those who have left bundle branch block (LBBB) stand to gain better long-term survival from receiving cardiac resynchronization therapy (CRT) in addition to a defibrillator. In contrast, those without the …
Boston Scientific’s MADIT-CRT study shows sustained survival benefit for mild …pharmabiz.com
Positive MADIT-CRT Data at Boston ScientificZacks.com
Boston Scientific Reports Key Data For CRT, Platinum Chromium Stents, TAVRRTT News
The Providence Journal
all 8 news articles »
01Apr/14

A New Novartis Heart Failure Drug Might Be A Blockbuster – Forbes

Organ Failure

Headlines & Global News

A New Novartis Heart Failure Drug Might Be A Blockbuster
Forbes
I try to avoid using words like “blockbuster” and “breakthrough” when writing about new drugs and treatments. I’ve been disappointed too many times. But, though they’ve been in short supply lately in cardiovascular medicine, sometimes there really are …
DMC recommends early closure of Novartis’ study of LCZ696 for chronic heart …pharmabiz.com
Novartis to Seek Approval Earlier than Expected for Chronic Heart Failure …Headlines & Global News
Novartis’ dual-action heart failure drug aces trialPMLiVE
Wall Street Journal –The Almagest –Reuters
all 57 news articles »